病患血液管理市場規模、佔有率、成長分析（按產品、組件、最終用戶和地區）- 產業預測，2025 年至 2032 年

2023 年患者血液管理市場規模價值 137.9 億美元，預計將從 2024 年的 146.6 億美元成長到 2032 年的 239 億美元，預測期內（2025-2032 年）的複合年成長率為 6.30%。

患者血液管理 (PBM) 市場正在經歷顯著成長，這得益於慢性病患病率的上升和外科手術的激增，以及人們對 PBM 益處的認知不斷提高。這種綜合方法旨在加強對需要輸血的患者的護理並改善結果，同時最大限度地減少對輸血的依賴。主要的市場驅動力包括心血管疾病和癌症等通常需要手術治療的疾病的發生率不斷上升。醫療保健提供者正在轉向 PBM 策略，以減輕輸血的風險和併發症。手術結果的改善、併發症的減少和住院時間的縮短正在推動對 PBM 解決方案的需求。透過推廣輸血替代方案和最佳化患者血液容量，PBM 實踐正擴大被納入全球醫療保健通訊協定。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2023年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

病患血液管理市場規模：依產品及複合年成長率（2024-2031）

• 市場概覽
• 裝置
• 血液處理設備
  • 離心
  • 血球處理設備
• 輸血設備
  • 血液採集機
  • 細胞恢復系統
• 血液培養篩檢裝置
  • 自動化血液培養系統
  • 支援的設備
• 診斷和測試設備
  • 聚合酵素鏈鎖反應
  • 血液分析儀
  • 血型測定儀
  • 次世代定序（NGS）平台
  • 其他
• 血液儲存裝置
  • 冰箱
  • 冷凍庫
• 配件
• 注射器和針頭
• 管瓶和試管
• 血袋
• 其他配件
• 試劑和套件
• 培養基
• 血型試劑
• 玻片染色
• 檢測試劑套件
• 其他
• 軟體
• 血庫和輸血軟體
• 其他

病患血液管理市場規模（依組成部分及複合年成長率） (2024-2031)

• 市場概覽
• 全血
• 血液成分

病患血液管理市場規模（按最終用戶和複合年成長率） (2024-2031)

• 市場概覽
• 醫院
• 血庫

病患血液管理市場規模：按地區和複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益年比比較（2021-2023年）

主要企業簡介

• Haemonetics Corporation（USA）
• Macopharma（France）
• Terumo Corporation（Japan）
• B. Braun SE（Germany）
• Grifols, SA（Spain）
• Asahi Kasei Corporation（Japan）
• BioMerieux SA（France）
• LivaNova PLC（UK）
• Fresenius Kabi AG（Germany）
• Roche Holding AG（Switzerland）
• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Medtronic plc.（Ireland）
• BD（Becton, Dickinson and Company）（USA）
• Cardinal Health（USA）
• Teleflex Incorporated（USA）
• Stryker Corporation（USA）

結論和建議

Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

The patient blood management market is witnessing substantial growth, propelled by rising chronic disease prevalence and a surge in surgical procedures, alongside heightened awareness of PBM benefits. This comprehensive approach enhances patient care for those requiring blood transfusions, aiming to improve outcomes while minimizing transfusion reliance. Key market drivers include the increasing incidence of conditions such as cardiovascular issues and cancers that typically necessitate surgery. Healthcare providers are gravitating towards PBM strategies to lessen transfusion risks and complications. The focus on enhancing surgical outcomes, reducing complications, and decreasing hospital stays fuels the demand for PBM solutions. By promoting alternatives to transfusions and optimizing patient blood volumes, PBM practices are becoming increasingly integrated into global healthcare protocols.

Top-down and bottom-up approaches were used to estimate and validate the size of the Patient Blood Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Patient Blood Management Market Segments Analysis

Global Patient Blood Management Market is segmented by product, component, end user and region. Based on product, the market is segmented into instruments, blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, blood storage devices, accessories, syringes & needles, vials & tubes, blood bags, other accessories, reagents and kits, culture media, blood typing reagents, slide staining, assay kits, others, software, blood bank and transfusion software and others. Based on component, the market is segmented into whole blood and blood components. Based on end user, the market is segmented into hospitals and blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Patient Blood Management Market

The transfusion medicine sector has seen remarkable advancements, characterized by the introduction of innovative techniques and technologies aimed at enhancing blood management. These developments have greatly elevated the safety and efficacy of blood transfusions, fostering a growing inclination towards implementing patient blood management practices. As healthcare providers increasingly recognize the benefits of these improvements, the demand for efficient blood management solutions continues to rise, ultimately leading to better patient outcomes. This ongoing evolution in blood transfusion methods is crucial in driving the overall growth of the patient blood management market.

Restraints in the Patient Blood Management Market

The adoption of patient blood management practices generally requires a shift away from traditional transfusion methods and established medical standards. This transition is met with challenges such as overcoming resistance to change, addressing the preferences of healthcare providers, and ensuring sufficient training and education for all involved parties. These factors can hinder the effective implementation and broader acceptance of patient blood management strategies, as stakeholders may be reluctant to abandon familiar procedures in favor of newer protocols aimed at improving patient outcomes. Overcoming these obstacles is essential for fostering a more efficient and effective patient care environment.

Market Trends of the Patient Blood Management Market

The global Patient Blood Management (PBM) market is witnessing a notable trend towards personalized and evidence-based strategies to enhance blood transfusion practices. This shift underscores the necessity of customizing transfusion protocols to align with individual patient profiles and clinical circumstances, moving away from a generic methodology. Healthcare institutions are increasingly aware of the associated risks of unnecessary blood transfusions-including transfusion reactions, infectious complications, and escalated healthcare expenses. Consequently, there is a growing investment in data analytics and technology solutions aimed at improving decision-making processes and ensuring optimal blood utilization, thereby transforming the PBM landscape into a more patient-centric approach.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Patient Blood Management Market Size by Product & CAGR (2024-2031)

• Market Overview
• Instruments
• Blood Processing Devices
  • Centrifuge
  • Blood Cell Processors
• Blood Transfusion Devices
  • Apheresis Machines
  • Cell Salvage Systems
• Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Equipment
• Diagnostic & Testing Instruments
  • Polymerase Chain Reaction
  • Hematology Analyzer
  • Blood Grouping Analyzers
  • Next-Generation Sequencing (Ngs) Platforms
  • Others
• Blood Storage Devices
  • Refrigerator
  • Freezers
• Accessories
• Syringes & Needles
• Vials & Tubes
• Blood Bags
• Other Accessories
• Reagents And Kits
• Culture Media
• Blood Typing Reagents
• Slide Staining
• Assay Kits
• Others
• Software
• Blood Bank And Transfusion Software
• Others

Global Patient Blood Management Market Size by Component & CAGR (2024-2031)

• Market Overview
• Whole Blood
• Blood Components

Global Patient Blood Management Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Blood Banks

Global Patient Blood Management Market Size & CAGR (2024-2031)

• North America (Product, Component, End User)
  • US
  • Canada
• Europe (Product, Component, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Component, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Component, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Component, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations